42 U.S.C. § 280g–8
(a)
Definitions— In this section:
(1)
Down syndrome— The term “Down syndrome” refers to a chromosomal disorder caused by an error in cell division that results in the presence of an extra whole or partial copy of chromosome 21.
(2)
Health care provider— The term “health care provider” means any
person or entity required by
State or Federal law or regulation to be licensed, registered, or certified to provide health care
services, and who is so licensed, registered, or certified.
(3)
Postnatally diagnosed condition— The term “postnatally diagnosed condition” means any health condition identified during the 12-month period beginning at birth.
(4)
Prenatally diagnosed condition— The term “prenatally diagnosed condition” means any fetal health condition identified by prenatal genetic testing or prenatal screening procedures.
(5)
Prenatal test— The term “prenatal test” means diagnostic or screening tests offered to pregnant women seeking routine prenatal care that are administered on a required or recommended basis by a
health care provider based on medical history,
family background, ethnic background, previous test results, or other risk factors.
(b)
Information and support services—
(1)
In general— The
Secretary, acting through the
Director of the National Institutes of Health, the
Director of the Centers for Disease Control and Prevention, or the
Administrator of the Health Resources and
Services Administration, may authorize and oversee certain activities, including the awarding of grants, contracts or cooperative
agreements to
eligible entities,
to—
(B)
coordinate the provision of, and access to, new or existing
supportive services for patients receiving a positive diagnosis for
Down syndrome or other prenatally or
postnatally diagnosed conditions,
including—
(i)
the establishment of a resource telephone hotline accessible to patients receiving a positive test result or to the
parents of newly diagnosed infants with
Down syndrome and other diagnosed conditions;
(ii)
the expansion and further development of the National Dissemination Center for
Children with Disabilities, so that such Center can more effectively conduct outreach to new and expecting
parents and provide them with up-to-date information on the range of outcomes for individuals living with the diagnosed condition, including physical, developmental, educational, and psychosocial outcomes;
(2)
Eligible entity— In this subsection, the term “eligible entity” means—
(3)
Distribution— In distributing
funds under this subsection, the
Secretary shall place an emphasis on funding partnerships between health care professional groups and disability advocacy organizations.
(c)
Provision of information to providers—
(1)
In general— A grantee under this section shall make available to
health care providers of
parents who receive a prenatal or postnatal diagnosis the following:
(A)
Up-to-date, evidence-based, written information concerning the range of outcomes for individuals living with the diagnosed condition, including physical, developmental, educational, and psychosocial outcomes.
(2)
Informational requirements— Information provided under this subsection shall be—
(A)
culturally and linguistically appropriate as needed by women receiving a positive prenatal diagnosis or the
family of infants receiving a postnatal diagnosis; and
(d)
Report— Not later than 2 years after October 8, 2008, the Government Accountability
Office shall submit a report to Congress concerning the effectiveness of current healthcare and
family support
programs serving as resources for the
families of
children with disabilities.
Notes, amendments, and revision history
(July 1, 1944, ch. 373, title III, § 399T, formerly § 399R, as added Pub. L. 110–374, § 3, Oct. 8, 2008, 122 Stat. 4051; renumbered § 399T, Pub. L. 111–148, title IV, § 4003(b)(2)(B), Mar. 23, 2010, 124 Stat. 544.)
Editorial Notes
References in Text
Section 2(b)(1) of the Prenatally and Postnatally Diagnosed Conditions Awareness Act, referred to in subsec. (b)(1)(B)(v), probably means section 2(1) of that Act, Pub. L. 110–374, which is set out as a note under this section.
Statutory Notes and Related Subsidiaries
Purposes
Pub. L. 110–374, § 2, Oct. 8, 2008, 122 Stat. 4051, provided that: “It is the purpose of this Act [enacting this section and provisions set out as a note under section 201 of this title] to— increase patient referrals to providers of key support services for women who have received a positive diagnosis for Down syndrome, or other prenatally or postnatally diagnosed conditions, as well as to provide up-to-date information on the range of outcomes for individuals living with the diagnosed condition, including physical, developmental, educational, and psychosocial outcomes; strengthen existing networks of support through the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and other patient and provider outreach programs; and ensure that patients receive up-to-date, evidence-based information about the accuracy of the test.”